Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Similar documents
Imaging to select patients for Transcatheter TV

Percutaneous technologies to correct TR : Myth or Reality? Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan

Management of Tricuspid Regurgitation

Concomitant Tricuspid Valve Repair :

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

Atrioventricular valve repair: The limits of operability

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD

Surgical AF Ablation : Lesion Sets and Energy Sources. What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan

The Key Questions in Mitral Valve Interventions. Where Are We in 2018?

Asymptomatic Valvular Disease:

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

When Does 3D Echo Make A Difference?

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients?

Chronic Primary Mitral Regurgitation

Tricuspid and Pulmonary Valve Disease

Repair or Replacement

The Tricuspid Valve: The Not So Forgotten Valve. Manuel J Antunes Cardiothoracic Surgery Coimbra, Portugal

Results of Aortic Valve Preservation and Repair

I have financial relationships to disclose Honoraria from: Edwards

Surgery For Ebstein Anomaly

Index. B B-type natriuretic peptide (BNP), 76

What is Ebstein Anomaly?

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Cover Page. The handle holds various files of this Leiden University dissertation.

Management of TR in Patients Undergoing Mitral Interventions

Tricuspid leaflet repair: innovative solutions

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.

Haiping Wang 1,2, Xiancheng Liu 2, Xin Wang 2, Zhenqian Lv 2, Xiaojun Liu 2, Ping Xu 1. Introduction

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France

What is the Role of Surgical Repair in 2012

Concomitant tricuspid valve repair in patients with minimally invasive mitral valve surgery

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Assessing the Impact on the Right Ventricle

Management of Difficult Aortic Root, Old and New solutions

Ischemic Mitral Regurgitation

How to assess ischaemic MR?

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

SONOGRAPHER & NURSE LED VALVE CLINICS

Assessment of Tricuspid and Pulmonic Valve Disease: Importance of 3D

Basic principles of Rheumatic mitral valve Repair

Surgical Repair of the Mitral Valve Presenter: Graham McCrystal Cardiothoracic Surgeon Christchurch Public Hospital

Restoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery

Quality Outcomes Mitral Valve Repair

Mitral valve treatment in advanced heart failure: Repair, Replacement, MitraClip. Nicola Buzzatti, MD San Raffaele Scientific Institute Milan, Italy

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Prognostic Impact of FMR

Clinical material and methods. Fukui Cardiovascular Center, Fukui, Japan

Evolving Indications for Tricuspid Valve Surgery

The HRT Mitral Bridge Technology for Functional MR

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

NeoChord Mitral Valve Repair. Department of Cardiac, Thoracic and Vascular Sciences University of Padua, Italy

Part II: Fundamentals of 3D Echocardiography: Acquisition and Application

What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA

Mohammad Sharif Popal, Jin-Tao Fu, Qiu-Ming Hu, Tian-Ge Luo, Shuai Zheng, Xu Meng

Aortic valve repair: When and how to employ this novel approach?

Primary Mitral Regurgitation

Tricuspid and Pulmonary Valve Disease

Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Functional Ischaemic Mitral Regurgitation: CABG + MV Replacement. Prakash P Punjabi. FRCS(Eng),FESC,MS,MCh,FCCP, Diplomate NBE

Tricuspid valve surgery in patients with a systemic right ventricle

Percutaneous Mitral Valve Repair

Echocardiographic Evaluation of Primary Mitral Regurgitation

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Transoesophageal echocardiography and decision making in valve surgery

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

Which patient undergoing mitral valve surgery should also have the tricuspid repair?

Percutaneous Mitral Valve Intervention: QuantumCor Device

Failed Aortic Valve Repairs Lessons Learned

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Percutaneous Mitral Valve Repair

Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada

Surgical Ablation: Which Lesion Set for Which Patient?

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

Ο ΡΟΛΟΣ ΤΩΝ ΚΟΛΠΩΝ ΣΤΗ ΛΕΙΤΟΥΡΓΙΚΗ ΑΝΕΠΑΡΚΕΙΑ ΤΩΝ ΚΟΛΠΟΚΟΙΛΙΑΚΩΝ ΒΑΛΒΙΔΩΝ

Steven F Bolling Professor of Cardiac Surgery University of Michigan

CLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ;

Emergency Intraoperative Echocardiography

M-Mode Echocardiography Is it still Alive? Itzhak Kronzon, MD,FASE. Sampling Rate M-Mode: 1800 / sec 2D: 30 / sec

Techniques for ischemic mitral valve disease: An Update. Stanford CV Surgery

The Edge-to-Edge Technique f For Barlow's Disease

Persistent Tricuspid Regurgitation After Tricuspid Annuloplasty During Redo Valve Surgery Affects Late Survival and Valve-Related Events

What echo measurements are key prior to MitraClip?

Surgical repair techniques for IMR: future percutaneous options?

Aortic stenosis with concomitant mitral regurgitation

Late Outcome of Tricuspid Annuloplasty Using a Flexible Band/Ring for Functional Tricuspid Regurgitation

Concomitant mitral valve replacement and tricuspid valvuloplasty for severe mitral stenosis

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Despite advances in our understanding of the pathophysiology

SURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK

Transcription:

Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery

Nath J, et al. JACC 2004

PREDICT

Incidence of secondary TR after MV surgery up to 50% of mitral valve (MV) surgery patients develop tricuspid regurgitation (TR) to various degrees. impacts secondary TR mortality : 1 year survival Absent TR, 91 % Mild TR, 90 % Moderate TR 70% Severe TR 60%

The Mayo Clinic Data Conclusion at 5 years relies upon 109 pts ONLY (out of initial cohort of 696 ) TR is separated into 1+ / 2+ vs 3+ / 4+ ( n= 109 ) Preop 1+ / 2+ : n = 93 3+ / 4+ : n = 15 ( 13 % ) Postop 1+ / 2+ : n = 77 3+ / 4+ : n = 32 ( 29,4 % ) Yilmaz O., Suri R.M. et al, J Thorac Cardiovasc Surg. 2011 Jan 28

N=699. MV repair without TV intervention Yilmaz O., Suri R.M. et al, J Thorac Cardiovasc Surg. 2011 Jan 28

Secondary tricuspid dilatation with or without regurgitation Postoperative tricuspid regurgitation TR grade M.V.R. M.V.R.+T.V.R. pre post pre post 0 54 8 38 102 1 102 33 92 41 2 7 67 16 4 3 0 40 2 1 30% 4 0 15 0 0 Dreyfus GD et al: Ann. Thorac. Surg. 2005; 79 : 127-32

TRICUSPID VALVE REPAIR DURING MV SURGERY: Why? TR grade Baseline 5 years p 0 54 8 1 102 33 2 7 67 3 0 40 4 0 15 Mean 0.7 ± 0.5 2.1 ± 1.0 < 0.001 163 patients undergoing mitral valve repair. Significant late TR developed in 34% of patients. Dreyfus GD, et al. Ann ThoracSurg 2005

TRICUSPID VALVE REPAIR DURING MV SURGERY: When? AHA/ACC 2006 Guidelines for TR management European Society of Cardiology. 2007 Indications for intervention in functional TR Class Severe TR in a patient undergoing left sided valve surgery I C Moderate secondary TR with dilated annulus (>40mm) in a patient undergoing left sided valve surgery IIa C

TR ASSESSMENT BEFORE SURGERY Pre-operative T.R. assessment is NOT reliable TR severity is dependent on physiological conditions which cannot be controlled / quantified -preload - afterload - RV function Changes in preload, afterload can unmask previously undiagnosed significant TR.

TR - STANDARD ASSESSMENT Echocardiography Assessment No TR - mild TR mild TR moderate TR severe TR

TR ASSESSMENT BEFORE SURGERY Annular dilatation is more relevant than regurgitation grading Tricuspid annular diameter > 3.4 cm seems a better marker than TR grading to predict secondary significant TR

Proposal for a «New Assessment» TR GRADING No TR / Mild TR Mild TR / Moderate TR Severe TR LEAFLET COAPTATION MODE At annular plane Below annular plane Surface vs edge to edge ANNULAR DILATATION Below 35/ 40 mm Above 35/40 mm

FUNCTIONAL AND ANATOMICAL TR CLASSIFICATION Stage 1 Stage 2 Stage 3 No TR/ mild TR Mild / Moderate TR Severe TR No TAD dilation TAD dilation Normal leaflet coaptation Little coaptation/ No effective coaptation Lack of coaptation with or without leaflet tethering (tethering height >8 mm)

FUNCTIONAL AND ANATOMICAL TR CLASSIFICATION STAGE 1

FUNCTIONAL AND ANATOMICAL TR CLASSIFICATION Stage 2 Mild TR/ Moderate TR TAD dilation Little coaptation/no effective coaptation

FUNCTIONAL AND ANATOMICAL TR CLASSIFICATION STAGE 2

FUNCTIONAL AND ANATOMICAL TR CLASSIFICATION STAGE 2

FUNCTIONAL AND ANATOMICAL TR CLASSIFICATION Stage 3 Severe TR Lack of coaptation WITH or WITHOUT LEAFLET TETHERING (tethering height >8 mm)

FUNCTIONAL AND ANATOMICAL TR CLASSIFICATION Stage 3

PREDICT

What the guidelines ignore?

What the guidelines ignore? 1.TRICUSPID ANNULAR DILATATION Normal tricuspid annular diameter: 35 mm. Dilated > 70 mm in 48% of patients undergoing mitral valve surgery. Dreyfus GD Ann ThoracSurg 2005

What the guidelines ignore? 2. ABNORMAL COAPTATION MODE EDGE TO EDGE COAPTATION NO COAPTATION SEVERE TETHERING

What the guidelines ignore? 3. Less than moderate TR in patients undergoing MV surgery

Others determinants of late TR Longer time from onset of MV disease to surgery Wang Larger LA Song et al. Atrial fibrillation Kim et al Dysfunction of mitral prosthesis Shiran and Sagie Right chambers dilatation De Bonis

PREVENT

FUNCTIONAL AND ANATOMICAL TR CLASSIFICATION Stage 1 Stage 2 Stage 3 No TR/ mild TR Mild / Moderate TR Severe TR No TAD dilation TAD dilation Normal leaflet coaptation Little coaptation/ No effective coaptation Lack of coaptation with or without leaflet tethering (tethering height >8 mm)

TRICUSPID VALVE REPAIR DURING MV SURGERY: HOW? Stage 1 No annuloplasty Stage 2- annuloplasty alone when TAD > 70 mm in operative room (Echo based /Surgical checking ) Stage 3 -annuloplasty alone ( without tethering) -complex REPAIR (with tethering) achieve TV coaptation

BEST VALUES OF PREDICTORS OF FUNCTIONAL TR Kim HK et al. Am J Cardiol 2006

Tethering & Annular Dilatation

Tethering & Annular Dilatation

METHODS Study aim To determine the effects of tricuspid leaflet augmentation on indices of tricuspid leaflet tethering Inclusion criteria All patients receiving concomitant tricuspid valve repair. Study period 1 March 2009 and 31 May 2010.

METHODS Tricuspid valve assessment 1. TR severity 0: none, 1: mild, 2: moderate, 3: severe 2. Annular diameter Distance between insertion sites of septal and anterior leaflets in four-chambers view 3. Tethering indices Tethering height Tenting area

METHODS Indications for concomitant tricuspid valve repair Irrespective of TR grading Significant tricuspid annular dilatation > 40 mm by echo > 70 mm intra-operatively Indications for anterior leaflet augmentation Significant leaflet tethering Tethering height > 8 mm.

METHODS Group 1 (n = 43) Tricuspid annuloplasty alone performed. CE Classic Tricuspid Annuloplasty Ring. Sized by measurement of anterior leaflet. Group 2 (n = 13) Complex tricuspid repair with AL Augmentation Tricuspid annuloplasty + leaflet augmentation.

RESULTS - BASELINE Group 1 Annuloplasty Group 2 AL Augmentation p Age (years) 65.9 (2.3) 58.2 (6.0) 0.15 NYHA class (1 4) 2.8 (0.2) 3.5 (0.2) 0.03 LVESD (mm) 38.9 (1.3) 36.2 (2.8) 0.35 Ejection fraction (%) 63.8 (1.7) 56.3 (3.4) 0.04 PA (mmhg) 40.6 (2.0) 50.3 (6.2) 0.06

RESULTS - BASELINE Group 1 Annuloplasty Group 2 AL Augmentation p Tricuspid valve data TR grade (0 3) 2.0 (0.1) 2.9 (0.1) 0.0002 Ann diameter (mm) 43.4 (0.6) 43.8 (1.1) 0.89 Tethering height (mm) 7.5 (0.4) 12.4 (1.0) <0.0001 Tethering area (mm 2 ) 188.0 (15.6) 354.4 (30.0) 0.0001

RESULTS - OPERATIVE Group 1 Annuloplasty Group 2 AL Augmentation p CPB time (min) 127.5 (6.0) 133.9 (11.2) 0.55 Cross clamp time (min) 101.1 (5.4) 95.1 (10.4) 0.64 Annuloplasty ring size (mm) 32.6 (0.3) 32.5 (0.5) 0.77 Associated procedures 39 MV surgery 4 AVR 5 AF ablation 1 CABG 1 ASD closure 10 MV surgery 1 AVR 2 CABG 2 AV repair

RESULTS POST-OP Changes in RV dimensions (Group 1: Annuloplasty)

RESULTS POST-OP Changes in RV dimensions (Group 2: Leaflet Augmentation)

RESULTS POST-OP Group 1 Annuloplasty Group 2 AL Augmentation P TR grade (0 3) 0.4 (0.1) 0.7 (0.3) 0.15 Tethering height mm mm % 6.4 (0.3) 0.9 (0.4) 10.0 (4.4) 7.6 (0.6) 4.5 (1.0) 30.6 (8.4) 0.04 0.0001 0.03 Tethering area mm 2 mm 2 % 107 (7) 63 (11) 28.5 (4.8) 131 (12) 191 (29) 56.5 (4.5) 0.19 <0.0001 0.004

CONCLUSION Functional tricuspid pathology should be revised completely taking into consideration : - grading / annular dilatation / leaflet coaptation Significant leaflet tethering is an entity of its own - which is not addressed by annuloplasty alone - which can explain high incidence of early failure after tricuspid annuloplasty

Tricuspid regurgitation (TR) grade Stulak J. M. et al.; Ann Thorac Surg 2008;86:40 45 Copyright 2008 The Society of Thoracic Surgeons